ZipRecruiter

Log In

1

Contract Biotech Investor Relations Jobs (NOW HIRING)

AmpersandPeople

Manager, Investor Relations

Manhattan, NY · On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

AmpersandPeople

Manager, Investor Relations

Manhattan, NY · On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

Travere

Analyst, Investor Relations

San Diego, CA

Department: 101200 Investor Relations Location: San Diego Be a part of a global team that is ... Strong interest in capital markets, investing, biotechnology, healthcare, and current events ...

Zenas BioPharma

Director, Investor Relations

Waltham, MA · Hybrid

$188K - $235K/yr

Zenas BioPharma is seeking an accomplished Director of Investor Relations to lead the development ... biotechnology or the life sciences; experience in a publicly traded biotech company strongly ...

Azenta

Vice President, Investor Relations

Burlington, MA

$248K - $310K/yr

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

Azenta

Vice President, Investor Relations

Burlington, MA · On-site

$248K - $310K/yr

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

Therakos

Head of Investor Relations

Bridgewater, NJ · On-site

Job Title Head of Investor Relations Requisition JR000015345 Head of Investor Relations (Open ... Prior pharmaceutical/biotech experience is required. * Strong understanding of financial statements ...

Mallinckrodt

Head of Investor Relations

Bridgewater, NJ · On-site

Job Title Head of Investor Relations Requisition JR000015345 Head of Investor Relations (Open ... Prior pharmaceutical/biotech experience is required. * Strong understanding of financial statements ...

next page

Showing results 1-20

All JobsContract Biotech Investor Relations Jobs

Contract Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do contract biotech investor relations jobs pay per year?

As of Jul 29, 2026, the average yearly pay for contract biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What are the key skills and qualifications needed to thrive as a Contract Biotech Investor Relations professional, and why are they important?

To thrive as a Contract Biotech Investor Relations professional, you need a solid background in finance, biotechnology, and communications, often supported by a relevant degree and industry experience. Familiarity with financial modeling tools, investor databases, CRM systems, and compliance platforms is typically required. Exceptional interpersonal skills, strategic thinking, and the ability to distill complex scientific concepts for diverse stakeholders are crucial soft skills in this role. These competencies are essential for building investor trust, ensuring regulatory compliance, and effectively communicating a company's value proposition to the financial community.

What is the difference between Contract Biotech Investor Relations vs Contract Biotech Communications?

AspectContract Biotech Investor RelationsContract Biotech Communications
Primary FocusManaging investor relations, financial communication, and shareholder engagementDeveloping public relations, media outreach, and brand messaging
Required SkillsFinancial analysis, investor communication, regulatory complianceMedia relations, content creation, branding strategies
Work EnvironmentCorporate offices, investor meetings, financial eventsMedia outlets, marketing agencies, corporate communications teams

Contract Biotech Investor Relations primarily focuses on managing relationships with investors and communicating financial information, while Contract Biotech Communications emphasizes public relations and brand messaging. Both roles require strong communication skills but serve different strategic purposes within biotech companies.

What are the main challenges faced by a Contract Biotech Investor Relations professional when communicating complex scientific information to investors?

A Contract Biotech Investor Relations professional often faces the challenge of translating intricate scientific data and clinical trial results into clear, compelling messages that investors can understand. Balancing technical accuracy with investor accessibility is crucial, as miscommunication can impact investor confidence and company reputation. Additionally, keeping up with rapidly evolving scientific developments and regulatory updates, while responding promptly to investor inquiries, requires strong communication and project management skills.

What are Contract Biotech Investor Relations professionals?

Contract Biotech Investor Relations professionals are specialists hired on a temporary or project basis to manage communications between biotechnology companies and their investors. They help ensure that all investor communications, financial disclosures, and company updates are clear, compliant, and strategically aligned with the company's goals. These professionals often support fundraising efforts, prepare investor materials, coordinate meetings, and handle inquiries from current or potential investors. Their expertise helps biotech companies build and maintain strong relationships with the investment community, especially during pivotal events such as clinical trial announcements or capital raises.
More about Contract Biotech Investor Relations jobs
What cities are hiring for Contract Biotech Investor Relations jobs? Cities with the most Contract Biotech Investor Relations job openings:
What are the most commonly searched types of Biotech Investor Relations jobs? The most popular types of Biotech Investor Relations jobs are:
What states have the most Contract Biotech Investor Relations jobs? States with the most job openings for Contract Biotech Investor Relations jobs include:
What job categories do people searching Contract Biotech Investor Relations jobs look for? The top searched job categories for Contract Biotech Investor Relations jobs are:
Contract Biotech Investor Relations jobs near you
Infographic showing various Contract Biotech Investor Relations job openings in the United States as of July 2026, with employment types broken down into 1% Locum Tenens, 2% As Needed, 89% Full Time, 1% Part Time, 1% Temporary, and 6% Contract. Highlights an 82% Physical, 3% Hybrid, and 15% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Associate Director, Investor Relations

Beam Therapeutics

Cambridge, MA • On-site

Other

Re-posted 11 days ago

Job description

Position Overview:

Beam is seeking a highly motivated and strategic Associate Director, Investor Relations to join our growing Investor Relations and External Communications team at a pivotal moment in the company's evolution. In this role, you will support the execution of Beam's investor relations strategy and play a central part in shaping how Beam's science, pipeline, and corporate narrative are communicated to the investment community. You will partner closely with senior leadership, finance, legal, corporate communications, and program teams to translate complex clinical and scientific milestones into clear, compelling, investor-ready messaging across earnings cycles, conferences, and one-on-one engagements. This position is critical to building a best-in-class IR function as Beam transitions from a clinical-stage to commercial-stage biotechnology company delivering on the promise of base editing for patients with serious diseases.

Key Responsibilities:

  • Support execution of Beam's investor relations strategy, including proactive engagement with buy-side and sell-side investors.
  • Help manage investor targeting, outreach, and meeting coordination for one-on-ones, conferences, and non-deal roadshows.
  • Track investor sentiment, ownership trends, and peer activity to inform outreach strategy and positioning.
  • Serve as a secondary point of contact for inbound investor and analyst inquiries.
  • Support continuous improvement of IR best practices and infrastructure.
  • Support preparation of key disclosures and quarterly earnings materials, including scripts, slide decks, Q&A documents, and press releases.
  • Help ensure accuracy, consistency, and compliance across external disclosures in coordination with legal and finance.
  • Manage internal consensus models.
  • Work cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones; translate technical data into clear, investor-relevant narratives; and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution.
  • Help refine and maintain Beam's corporate narrative as the company evolves from a clinical-stage to commercial-stage biotech.
  • Assist in message testing and preparation of executive spokespeople.
  • Manage updates to Beam's investor website and coordinate with Corporate Communications on broader digital and website strategy and content.

Required Qualifications:

  • 5-8 years of experience in investor relations, equity research, investment banking, corporate finance, or strategic communications, with meaningful exposure to public biotechnology or life sciences companies.
  • Strong understanding of capital markets, public company disclosure requirements, and investor expectations.
  • Ability to synthesize complex scientific, clinical, and financial information into clear, concise messaging.
  • Proven written and verbal communication skills.
  • High attention to detail and strong project management capabilities.
  • Comfortable operating in a fast-paced, highly cross-functional environment.

Preferred Qualifications:

  • Prior experience supporting a pipeline-driven biotech company with multiple clinical programs.
  • Exposure to companies approaching or undergoing a transition to commercial stage.
  • Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities.
  • Experience interacting directly with investors or analysts.

Apply